PMID- 25814074
OWN - NLM
STAT- MEDLINE
DCOM- 20160229
LR  - 20221207
IS  - 2737-5935 (Electronic)
IS  - 0037-5675 (Print)
IS  - 0037-5675 (Linking)
VI  - 56
IP  - 5
DP  - 2015 May
TI  - Predictors of poor glycaemic control in older patients with type 2 diabetes 
      mellitus.
PG  - 284-90
LID - 10.11622/smedj.2015055 [doi]
AB  - INTRODUCTION: We assessed the predictors of poor glycaemic control among older 
      patients with type 2 diabetes mellitus (T2DM) in Malaysia. METHODS: This 
      cross-sectional study used the data of 21,336 patients aged >/= 60 years with T2DM 
      from the Adult Diabetes Control and Management Registry 2008-2009. RESULTS: 
      Predictors of poor glycaemic control were: age groups 60-69 years (odds ratio 
      [OR] 1.96, 95% confidence interval [CI] 1.66-2.33) and 70-79 years (OR 1.43, 95% 
      CI 1.20-1.71); Malay (OR 1.53, 95% CI 1.41-1.66) and Indian (OR 1.32, 95% CI 
      1.19-1.46) ethnicities; T2DM durations of 5-10 years (OR 1.46, 95% CI 1.35-1.58) 
      and > 10 years (OR 1.75, 95% CI 1.59-1.91); the use of oral antidiabetic agents 
      only (OR 5.86, 95% CI 3.32-10.34), insulin only (OR 17.93, 95% CI 9.91-32.43), 
      and oral antidiabetic agents and insulin (OR 29.42, 95% CI 16.47-52.53); and 
      elevated blood pressure (OR 1.10, 95% CI 1.01-1.20), low-density lipoprotein 
      cholesterol (OR 1.48, 95% CI 1.38-1.59) and triglycerides (OR 1.61, 95% CI 
      1.51-1.73). Hypertension (OR 0.71, 95% CI 0.64-0.80), hypertension and 
      dyslipidaemia (OR 0.68, 95% CI 0.61-0.75), pre-obesity (OR 0.89, 95% CI 
      0.82-0.98) and obesity (OR 0.76, 95% CI 0.70-0.84) were less likely to be 
      associated with poor glycaemic control. CONCLUSION: Young-old and middle-old age 
      groups (i.e. < 80 years), Malay and Indian ethnicities, longer T2DM duration, the 
      use of pharmacological agents, and elevated blood pressure and lipid levels were 
      associated with poor glycaemic control. The presence of comorbidities, 
      pre-obesity and obesity were less likely to be associated with poor glycaemic 
      control.
FAU - Sazlina, Shariff-Ghazali
AU  - Sazlina SG
AD  - Department of Family Medicine, Faculty of Medicine and Health Sciences, 
      Universiti Putra Malaysia, Serdang, Selangor, Malaysia ; Institute of 
      Gerontology, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
FAU - Mastura, Ismail
AU  - Mastura I
AD  - Seremban 2 Health Clinic, Seremban, Negeri Sembilan, Malaysia.
FAU - Cheong, Ai Theng
AU  - Cheong AT
AD  - Department of Family Medicine, Faculty of Medicine and Health Sciences, 
      Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
FAU - Bujang Mohamad, Adam
AU  - Bujang Mohamad A
AD  - Biostatistics Unit, National Clinical Research Centre, Ministry of Health, Kuala 
      Lumpur, Malaysia.
FAU - Jamaiyah, Haniff
AU  - Jamaiyah H
AD  - Clinical Epidemiology Unit, National Clinical Research Centre, Ministry of 
      Health, Kuala Lumpur, Malaysia.
FAU - Lee, Ping Yein
AU  - Lee PY
AD  - Department of Family Medicine, Faculty of Medicine and Health Sciences, 
      Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
FAU - Syed Alwi, Syed Abdul Rahman
AU  - Syed Alwi SA
AD  - Department of Family Medicine, Faculty of Medicine and Health Sciences, 
      Universiti Malaysia Sarawak, Kuching, Sarawak, Malaysia.
FAU - Chew, Boon How
AU  - Chew BH
AD  - Department of Family Medicine, Faculty of Medicine and Health Sciences, 
      Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - India
TA  - Singapore Med J
JT  - Singapore medical journal
JID - 0404516
RN  - 0 (Cholesterol, LDL)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (Hypoglycemic Agents)
RN  - 0 (Insulin)
RN  - 0 (Triglycerides)
RN  - 0 (hemoglobin A1c protein, human)
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Asian People
MH  - Blood Pressure
MH  - Cholesterol, LDL/blood
MH  - Comorbidity
MH  - Cross-Sectional Studies
MH  - Diabetes Mellitus, Type 2/*blood/*complications/ethnology
MH  - Female
MH  - Glycated Hemoglobin/metabolism
MH  - Humans
MH  - Hyperglycemia/*blood
MH  - Hypertension/complications
MH  - Hypoglycemic Agents/therapeutic use
MH  - Insulin/blood
MH  - Male
MH  - Middle Aged
MH  - Obesity/complications
MH  - Registries
MH  - Sex Factors
MH  - Singapore
MH  - Triglycerides/blood
PMC - PMC4447931
OTO - NOTNLM
OT  - Malaysia
OT  - diabetes mellitus
OT  - glycaemic control
OT  - older patients
OT  - registry
EDAT- 2015/03/31 06:00
MHDA- 2016/03/02 06:00
PMCR- 2015/05/01
CRDT- 2015/03/28 06:00
PHST- 2015/03/28 06:00 [entrez]
PHST- 2015/03/31 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
PHST- 2015/05/01 00:00 [pmc-release]
AID - SMJ-56-284 [pii]
AID - 10.11622/smedj.2015055 [doi]
PST - ppublish
SO  - Singapore Med J. 2015 May;56(5):284-90. doi: 10.11622/smedj.2015055.